Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
FGF19,Fibroblast growth factor 19,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.97 [0.94-1],0.0329707763721284,trans
FGF19,Fibroblast growth factor 19,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,4,0.97 [0.94-1],0.0338325633588009,trans
FGF19,Fibroblast growth factor 19,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,0.97 [0.94-1.01],0.175234507553057,trans
FGF19,Fibroblast growth factor 19,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,0.98 [0.96-1.01],0.278297055389278,trans
FGF19,Fibroblast growth factor 19,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.98 [0.93-1.03],0.457418931656757,trans
FGF19,Fibroblast growth factor 19,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Wald ratio,1,0.97 [0.85-1.1],0.61811707745052,trans
FGF19,Fibroblast growth factor 19,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,8,0.99 [0.96-1.02],0.624877579518077,trans
FGF19,Fibroblast growth factor 19,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,3,1.01 [0.96-1.06],0.787853472028682,trans
FGF19,Fibroblast growth factor 19,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,1 [0.95-1.06],0.923005842554392,trans
